CADAS138 emerges as a novel therapeutic target in the realm of inflammatory conditions. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to mitigate disease progression. Researchers are currently investigating the precise mechanisms of CADAS138 in disease pathogenesis, paving the way for the creation of novel th